151 related articles for article (PubMed ID: 32009931)
1. Two Cases of Very-Late-Onset Neuromyelitis Optica Spectrum Disorder (NMOSD) in Patients over the Age of 80.
Fujiwara S; Manabe Y; Morihara R; Yunoki T; Kono S; Narai H; Abe K
Case Rep Neurol; 2020; 12(1):13-17. PubMed ID: 32009931
[TBL] [Abstract][Full Text] [Related]
2. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
6. CLINICAL CASE OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS IN YOUNG WOMAN TREATED WITH RITUXIMAB.
Poiasnyk IM; Gryb VA
Wiad Lek; 2022; 75(1):132-137. PubMed ID: 35092262
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
11. Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Krumbholz M; Hofstadt-van Oy U; Angstwurm K; Kleiter I; Jarius S; Paul F; Aktas O; Buchholz G; Kern P; Straube A; Kümpfel T
J Neurol; 2015 May; 262(5):1379-84. PubMed ID: 25957640
[TBL] [Abstract][Full Text] [Related]
12. Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity.
Long Y; Liang J; Wu L; Lin S; Gao C; Chen X; Qiu W; Yang Y; Zheng X; Yang N; Gao M; Chen Y; Wang Z; Su Q
Front Neurol; 2017; 8():62. PubMed ID: 28293214
[TBL] [Abstract][Full Text] [Related]
13. [Clinical presentations of neuromyelitis optica spectrum disorders with ultra-longitudinally extensive transverse myelitis].
Huang X; Xu FF; Qian HR; Lei X; Qi XK; Xia DY
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(21):1658-1663. PubMed ID: 29925142
[No Abstract] [Full Text] [Related]
14. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
[TBL] [Abstract][Full Text] [Related]
16. [Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
Oshiro A; Nakamura S; Tamashiro K; Fujihara K
No To Hattatsu; 2016 May; 48(3):199-203. PubMed ID: 27349083
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
[No Abstract] [Full Text] [Related]
18. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
[TBL] [Abstract][Full Text] [Related]
19. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
Tao S; Zhang Y; Ye H; Guo D
Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
[TBL] [Abstract][Full Text] [Related]
20. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].
Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
